Global Peptide CDMO Market Growth (Status and Outlook) 2021-2026


Aug, 2021 | Report ID: 210632 | 113 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Peptide CDMO will have significant change from previous year. By the most conservative estimates of global Peptide CDMO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Peptide CDMO market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CDMO market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

LPPS

SPPS

Mixed Phase

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Pharmaceutical Industry

Cosmetics Industry

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Thermo Fisher Pharma

PolyPeptide

Bachem

ScinoPharm

CBL

AmbioPharm

Piramal Pharma

CordenPharma

CPC SCIENTIFIC

Provepharm

Space Peptides

Biopeptek

Alpha Biophama

Alabiochem

Aurigene Pharmaceutical Services

Chengdu Shengnuo Biotechnology Co., Ltd

Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Peptide CDMO Market Size 2016-2026

2.1.2 Peptide CDMO Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Peptide CDMO Segment by Type

2.2.1 LPPS

2.2.2 LPPS

2.2.3 Mixed Phase

2.3 Peptide CDMO Market Size by Type

2.3.1 Global Peptide CDMO Market Size CAGR by Type

2.3.2 Global Peptide CDMO Market Size Market Share by Type (2016-2021)

2.4 Peptide CDMO Segment by Application

2.4.1 Pharmaceutical Industry

2.4.2 Cosmetics Industry

2.4.3 Others

2.5 Peptide CDMO Market Size by Application

2.5.1 Global Peptide CDMO Market Size CAGR by Application

2.5.2 Global Peptide CDMO Market Size Market Share by Application (2016-2021)

3 Peptide CDMO Market Size by Players

3.1 Peptide CDMO Market Size Market Share by Players

3.1.1 Global Peptide CDMO Revenue by Players (2019-2021E)

3.1.2 Global Peptide CDMO Revenue Market Share by Players (2019-2021E)

3.2 Global Peptide CDMO Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Peptide CDMO by Regions

4.1 Peptide CDMO Market Size by Regions (2016-2021)

4.2 Americas Peptide CDMO Market Size Growth (2016-2021)

4.3 APAC Peptide CDMO Market Size Growth (2016-2021)

4.4 Europe Peptide CDMO Market Size Growth (2016-2021)

4.5 Middle East & Africa Peptide CDMO Market Size Growth (2016-2021)

5 Americas

5.1 Americas Peptide CDMO Market Size by Country (2016-2021)

5.2 Americas Peptide CDMO Market Size by Type (2016-2021)

5.3 Americas Peptide CDMO Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Peptide CDMO Market Size by Region (2016-2021)

6.2 APAC Peptide CDMO Market Size by Type (2016-2021)

6.3 APAC Peptide CDMO Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Peptide CDMO by Country (2016-2021)

7.2 Europe Peptide CDMO Market Size by Type (2016-2021)

7.3 Europe Peptide CDMO Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Peptide CDMO by Region (2016-2021)

8.2 Middle East & Africa Peptide CDMO Market Size by Type (2016-2021)

8.3 Middle East & Africa Peptide CDMO Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Peptide CDMO Market Forecast

10.1 Global Peptide CDMO Forecast by Regions (2021-2026)

10.1.1 Global Peptide CDMO Forecast by Regions (2021-2026)

10.1.2 Americas Peptide CDMO Forecast

10.1.3 APAC Peptide CDMO Forecast

10.1.4 Europe Peptide CDMO Forecast

10.1.5 Middle East & Africa Peptide CDMO Forecast

10.2 Americas Peptide CDMO Forecast by Countries (2021-2026)

10.2.1 United States Peptide CDMO Market Forecast

10.2.2 Canada Peptide CDMO Market Forecast

10.2.3 Mexico Peptide CDMO Market Forecast

10.2.4 Brazil Peptide CDMO Market Forecast

10.3 APAC Peptide CDMO Forecast by Region (2021-2026)

10.3.1 China Peptide CDMO Market Forecast

10.3.2 Japan Peptide CDMO Market Forecast

10.3.3 Korea Peptide CDMO Market Forecast

10.3.4 Southeast Asia Peptide CDMO Market Forecast

10.3.5 India Peptide CDMO Market Forecast

10.3.6 Australia Peptide CDMO Market Forecast

10.4 Europe Peptide CDMO Forecast by Country (2021-2026)

10.4.1 Germany Peptide CDMO Market Forecast

10.4.2 France Peptide CDMO Market Forecast

10.4.3 UK Peptide CDMO Market Forecast

10.4.4 Italy Peptide CDMO Market Forecast

10.4.5 Russia Peptide CDMO Market Forecast

10.5 Middle East & Africa Peptide CDMO Forecast by Region (2021-2026)

10.5.1 Egypt Peptide CDMO Market Forecast

10.5.2 South Africa Peptide CDMO Market Forecast

10.5.3 Israel Peptide CDMO Market Forecast

10.5.4 Turkey Peptide CDMO Market Forecast

10.5.5 GCC Countries Peptide CDMO Market Forecast

10.6 Global Peptide CDMO Forecast by Type (2021-2026)

10.7 Global Peptide CDMO Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Thermo Fisher Pharma

11.1.1 Thermo Fisher Pharma Company Information

11.1.2 Thermo Fisher Pharma Peptide CDMO Product Offered

11.1.3 Thermo Fisher Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Thermo Fisher Pharma Main Business Overview

11.1.5 Thermo Fisher Pharma Latest Developments

11.2 PolyPeptide

11.2.1 PolyPeptide Company Information

11.2.2 PolyPeptide Peptide CDMO Product Offered

11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 PolyPeptide Main Business Overview

11.2.5 PolyPeptide Latest Developments

11.3 Bachem

11.3.1 Bachem Company Information

11.3.2 Bachem Peptide CDMO Product Offered

11.3.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Bachem Main Business Overview

11.3.5 Bachem Latest Developments

11.4 ScinoPharm

11.4.1 ScinoPharm Company Information

11.4.2 ScinoPharm Peptide CDMO Product Offered

11.4.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 ScinoPharm Main Business Overview

11.4.5 ScinoPharm Latest Developments

11.5 CBL

11.5.1 CBL Company Information

11.5.2 CBL Peptide CDMO Product Offered

11.5.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 CBL Main Business Overview

11.5.5 CBL Latest Developments

11.6 AmbioPharm

11.6.1 AmbioPharm Company Information

11.6.2 AmbioPharm Peptide CDMO Product Offered

11.6.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 AmbioPharm Main Business Overview

11.6.5 AmbioPharm Latest Developments

11.7 Piramal Pharma

11.7.1 Piramal Pharma Company Information

11.7.2 Piramal Pharma Peptide CDMO Product Offered

11.7.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Piramal Pharma Main Business Overview

11.7.5 Piramal Pharma Latest Developments

11.8 CordenPharma

11.8.1 CordenPharma Company Information

11.8.2 CordenPharma Peptide CDMO Product Offered

11.8.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 CordenPharma Main Business Overview

11.8.5 CordenPharma Latest Developments

11.9 CPC SCIENTIFIC

11.9.1 CPC SCIENTIFIC Company Information

11.9.2 CPC SCIENTIFIC Peptide CDMO Product Offered

11.9.3 CPC SCIENTIFIC Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 CPC SCIENTIFIC Main Business Overview

11.9.5 CPC SCIENTIFIC Latest Developments

11.10 Provepharm

11.10.1 Provepharm Company Information

11.10.2 Provepharm Peptide CDMO Product Offered

11.10.3 Provepharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Provepharm Main Business Overview

11.10.5 Provepharm Latest Developments

11. Space Peptides

11.11.1 Space Peptides Company Information

11.11.2 Space Peptides Peptide CDMO Product Offered

11.11.3 Space Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Space Peptides Main Business Overview

11.11.5 Space Peptides Latest Developments

11.12 Biopeptek

11.12.1 Biopeptek Company Information

11.12.2 Biopeptek Peptide CDMO Product Offered

11.12.3 Biopeptek Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Biopeptek Main Business Overview

11.12.5 Biopeptek Latest Developments

11.13 Alpha Biophama

11.13.1 Alpha Biophama Company Information

11.13.2 Alpha Biophama Peptide CDMO Product Offered

11.13.3 Alpha Biophama Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Alpha Biophama Main Business Overview

11.13.5 Alpha Biophama Latest Developments

11.14 Alabiochem

11.14.1 Alabiochem Company Information

11.14.2 Alabiochem Peptide CDMO Product Offered

11.14.3 Alabiochem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Alabiochem Main Business Overview

11.14.5 Alabiochem Latest Developments

11.15 Aurigene Pharmaceutical Services

11.15.1 Aurigene Pharmaceutical Services Company Information

11.15.2 Aurigene Pharmaceutical Services Peptide CDMO Product Offered

11.15.3 Aurigene Pharmaceutical Services Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Aurigene Pharmaceutical Services Main Business Overview

11.15.5 Aurigene Pharmaceutical Services Latest Developments

11.16 Chengdu Shengnuo Biotechnology Co., Ltd

11.16.1 Chengdu Shengnuo Biotechnology Co., Ltd Company Information

11.16.2 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product Offered

11.16.3 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Chengdu Shengnuo Biotechnology Co., Ltd Main Business Overview

11.16.5 Chengdu Shengnuo Biotechnology Co., Ltd Latest Developments

11.17 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd

11.17.1 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Company Information

11.17.2 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product Offered

11.17.3 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Main Business Overview

11.17.5 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Peptide CDMO Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of LPPS

Table 3. Major Players of SPPS

Table 4. Major Players of Mixed Phase

Table 5. Peptide CDMO Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 6. Global Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 7. Global Peptide CDMO Market Size Market Share by Type (2016-2021)

Table 8. Peptide CDMO Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 9. Global Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 10. Global Peptide CDMO Market Size Market Share by Application (2016-2021)

Table 11. Global Peptide CDMO Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Peptide CDMO Revenue Market Share by Players (2019-2021E)

Table 13. Peptide CDMO Key Players Head office and Products Offered

Table 14. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Peptide CDMO Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Peptide CDMO Market Size Market Share by Regions 2016-2021

Table 19. Americas Peptide CDMO Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Peptide CDMO Market Size Market Share by Country (2016-2021)

Table 21. Americas Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 22. Americas Peptide CDMO Market Size Market Share by Type (2016-2021)

Table 23. Americas Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 24. Americas Peptide CDMO Market Size Market Share by Application (2016-2021)

Table 25. APAC Peptide CDMO Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Peptide CDMO Market Size Market Share by Region (2016-2021)

Table 27. APAC Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 28. APAC Peptide CDMO Market Size Market Share by Type (2016-2021)

Table 29. APAC Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 30. APAC Peptide CDMO Market Size Market Share by Application (2016-2021)

Table 31. Europe Peptide CDMO Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Peptide CDMO Market Size Market Share by Country (2016-2021)

Table 33. Europe Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 34. Europe Peptide CDMO Market Size Market Share by Type (2016-2021)

Table 35. Europe Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 36. Europe Peptide CDMO Market Size Market Share by Application (2016-2021)

Table 37. Middle East & Africa Peptide CDMO Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2016-2021)

Table 41. Middle East & Africa Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2016-2021)

Table 43. Key and Potential Regions of Peptide CDMO

Table 44. Key Application and Potential Industries of Peptide CDMO

Table 45. Key Challenges of Peptide CDMO

Table 46. Key Trends of Peptide CDMO

Table 47. Global Peptide CDMO Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Peptide CDMO Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Peptide CDMO Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 50. Global Peptide CDMO Market Size Market Share Forecast by Type (2021-2026)

Table 51. Global Peptide CDMO Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 52. Global Peptide CDMO Market Size Market Share Forecast by Application (2021-2026)

Table 53. Thermo Fisher Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 54. Thermo Fisher Pharma Peptide CDMO Product Offered

Table 55. Thermo Fisher Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. Thermo Fisher Pharma Main Business

Table 57. Thermo Fisher Pharma Latest Developments

Table 58. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 59. PolyPeptide Peptide CDMO Product Offered

Table 60. PolyPeptide Main Business

Table 61. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. PolyPeptide Latest Developments

Table 63. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 64. Bachem Peptide CDMO Product Offered

Table 65. Bachem Main Business

Table 66. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Bachem Latest Developments

Table 68. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 69. ScinoPharm Peptide CDMO Product Offered

Table 70. ScinoPharm Main Business

Table 71. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. ScinoPharm Latest Developments

Table 73. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 74. CBL Peptide CDMO Product Offered

Table 75. CBL Main Business

Table 76. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. CBL Latest Developments

Table 78. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 79. AmbioPharm Peptide CDMO Product Offered

Table 80. AmbioPharm Main Business

Table 81. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. AmbioPharm Latest Developments

Table 83. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 84. Piramal Pharma Peptide CDMO Product Offered

Table 85. Piramal Pharma Main Business

Table 86. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. Piramal Pharma Latest Developments

Table 88. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 89. CordenPharma Peptide CDMO Product Offered

Table 90. CordenPharma Main Business

Table 91. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. CordenPharma Latest Developments

Table 93. CPC SCIENTIFIC Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 94. CPC SCIENTIFIC Peptide CDMO Product Offered

Table 95. CPC SCIENTIFIC Main Business

Table 96. CPC SCIENTIFIC Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. CPC SCIENTIFIC Latest Developments

Table 98. Provepharm Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 99. Provepharm Peptide CDMO Product Offered

Table 100. Provepharm Main Business

Table 101. Provepharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. Provepharm Latest Developments

Table 103. Space Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 104. Space Peptides Peptide CDMO Product Offered

Table 105. Space Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Space Peptides Main Business

Table 107. Space Peptides Latest Developments

Table 108. Biopeptek Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 109. Biopeptek Peptide CDMO Product Offered

Table 110. Biopeptek Main Business

Table 111. Biopeptek Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Biopeptek Latest Developments

Table 113. Alpha Biophama Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 114. Alpha Biophama Peptide CDMO Product Offered

Table 115. Alpha Biophama Main Business

Table 116. Alpha Biophama Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 117. Alpha Biophama Latest Developments

Table 118. Alabiochem Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 119. Alabiochem Peptide CDMO Product Offered

Table 120. Alabiochem Main Business

Table 121. Alabiochem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 122. Alabiochem Latest Developments

Table 123. Aurigene Pharmaceutical Services Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 124. Aurigene Pharmaceutical Services Peptide CDMO Product Offered

Table 125. Aurigene Pharmaceutical Services Main Business

Table 126. Aurigene Pharmaceutical Services Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 127. Aurigene Pharmaceutical Services Latest Developments

Table 128. Chengdu Shengnuo Biotechnology Co., Ltd Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 129. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product Offered

Table 130. Chengdu Shengnuo Biotechnology Co., Ltd Main Business

Table 131. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 132. Chengdu Shengnuo Biotechnology Co., Ltd Latest Developments

Table 133. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Details, Company Type, Peptide CDMO Area Served and Its Competitors

Table 134. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product Offered

Table 135. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Main Business

Table 136. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 137. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Latest Developments

List of Figures

Figure 1. Peptide CDMO Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Peptide CDMO Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Peptide CDMO Market Size Market Share by Type in 2020

Figure 7. Peptide CDMO in Pharmaceutical Industry

Figure 8. Global Peptide CDMO Market: Pharmaceutical Industry (2016-2021) & ($ Millions)

Figure 9. Peptide CDMO in Cosmetics Industry

Figure 10. Global Peptide CDMO Market: Cosmetics Industry (2016-2021) & ($ Millions)

Figure 11. Peptide CDMO in Others

Figure 12. Global Peptide CDMO Market: Others (2016-2021) & ($ Millions)

Figure 13. Global Peptide CDMO Market Size Market Share by Application in 2020

Figure 14. Global Peptide CDMO Revenue Market Share by Player in 2020

Figure 15. Global Peptide CDMO Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Peptide CDMO Market Size 2016-2021 ($ Millions)

Figure 17. APAC Peptide CDMO Market Size 2016-2021 ($ Millions)

Figure 18. Europe Peptide CDMO Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Peptide CDMO Market Size 2016-2021 ($ Millions)

Figure 20. Americas Peptide CDMO Market Size Market Share by Country in 2020

Figure 21. Americas Peptide CDMO Market Size Market Share by Type in 2020

Figure 22. Americas Peptide CDMO Market Size Market Share by Application in 2020

Figure 23. United States Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Peptide CDMO Market Size Market Share by Regions in 2020

Figure 27. APAC Peptide CDMO Market Size Market Share by Type in 2020

Figure 28. APAC Peptide CDMO Market Size Market Share by Application in 2020

Figure 29. China Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Peptide CDMO Market Size Market Share by Country in 2020

Figure 36. Europe Peptide CDMO Market Size Market Share by Type in 2020

Figure 37. Europe Peptide CDMO Market Size Market Share by Application in 2020

Figure 38. Germany Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Peptide CDMO Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Peptide CDMO Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Application in 2020

Figure 46. Egypt Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Peptide CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 52. APAC Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 53. Europe Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 55. United States Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 56. Canada Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 59. China Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 60. Japan Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 61. Korea Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 63. India Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 64. Australia Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 65. Germany Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 66. France Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 67. UK Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 68. Italy Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 69. Russia Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 70. Spain Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 73. Israel Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Peptide CDMO Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Peptide CDMO Market Size 2021-2026 ($ Millions)

Sample Request is not available